Hemorrhage clinical trials at UCSF

1 research study open to eligible people

Hemorrhage is heavy loss of blood from the body. UCSF is running a study that gives calcium and vasopressin soon after injury. This is a double blind, multi site study planned over four years.

Showing trials for

  • CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

    open to eligible people ages 18-90

    The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.

    San Francisco, California and other locations

Last updated: